Hereditary
protein C deficiency is associated with a predisposition to
venous thrombosis. It is not clear whether the deficiency is involved in
arterial occlusion. In the present study, we screened for
protein C amidolytic activity in patients admitted to the National Cardiovascular Center Hospital, and we identified among them 43 probands and 51 relatives with heterozygous
protein C deficiency. Among them, 34 patients with heterozygous
protein C deficiency had manifested 45 episodes of
arterial occlusive disease. Venous thrombotic diseases were less common. In the examination of whether
protein C deficiency hastens
arterial occlusion, we found a significant difference (p =0.02) in the age at onset of acute
myocardial infarction between the patients with
protein C deficiency (n=10; 49.4+/-14.8 years) and a group of patients with normal
protein C levels (n=42; 60.5+/-10.6 years). Acute
myocardial infarction occurred before 40 years of age in a significantly greater proportion of the patients with
protein C deficiency (3:10, 30%) as compared with the controls (2:42, 5%) (chi2=5.9, p=0.015). At the onset of atherothrombotic
cerebral infarction the patients with
protein C deficiency were significantly (p=0.022) younger (n= 11; 57.4+/-12.8 years) than those with normal
protein C levels (n=48; 64.6+/-10.1 years).
Venous thrombosis was the most frequent clinical manifestation (21 of 31 episodes) in the patients with
antithrombin III deficiency (n=26; 68% of the total), who were admitted to our hospital. Thus, our study suggests that congenital
protein C deficiency contributes to earlier onset of
arterial occlusive diseases, especially acute
myocardial infarction, in Japanese subjects.